Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 16/20 | 0.86 |
| ▸ | PTGDR | Q13258 | 6/20 | 0.74 |
| ▸ | HTR6 | P50406 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.45 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
| ▸ | CCKAR | P32238 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6529582 | 0.94 | PTGDR2 (0.80) | PTGDR2PTGDRHTR6AKR1C3AKR1C2 | |
| SCHEMBL6529300 | 0.92 | PTGDR2 (0.72) | PTGDR2PTGDRAKR1C3AKR1C2TBXA2R | |
| SCHEMBL6529040 | 0.89 | PTGDR2 (0.73) | PTGDR2PTGDRCCKAR | |
| SCHEMBL6532462 | 0.88 | PTGDR2 (0.69) | PTGDR2PTGDRAKR1C3AKR1C2CCKAR | |
| SCHEMBL6533995 | 0.88 | PTGDR2 (0.73) | PTGDR2PTGDRAKR1C3AKR1C2CCKAR | |
| SCHEMBL6532747 | 0.88 | PTGDR2 (0.73) | PTGDR2PTGDRHTR6AKR1C3AKR1C2 | |
| SCHEMBL6528660 | 0.87 | PTGDR2 (0.68) | PTGDR2PTGDRCCKAR | |
| SCHEMBL6529278 | 0.85 | PTGDR2 (0.69) | PTGDR2PTGDRCCKAR | |
| SCHEMBL6531237 | 0.85 | PTGDR2 (0.68) | PTGDR2PTGDRAKR1C3AKR1C2CCKAR | |
| SCHEMBL6529089 | 0.85 | PTGDR2 (0.68) | PTGDR2PTGDRAKR1C3AKR1C2TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005040112-A1 | COMPOUNDS WITH PGD2 ANTAGONIST ACTIVITY | OXAGEN LIMITED (GB) | 2005-05-06 | — | — | WO | disclosed |